The Next Generation Vaccine Card: Innovative Technology to Improve Vaccine Equity in Rural and Urban Settings in East Africa
NCT06470919 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3522
Last updated 2025-12-03
Summary
The research team of investigators from University of Michigan and the African Population and Health Research Center will implement and evaluate a newly-developed digital vaccine card and accompanying mobile application and electronic immunization registry. This will take place in rural Uganda and urban Kenya Health and Demographic Surveillance Systems (HDSS) and the study team will analyze its feasibility, impacts, cost through process, and economic evaluations. The study team will also assess the data quality and equity of the digital vaccine registry and card system.
Conditions
- Vaccines
Interventions
- OTHER
-
SMS reminders for upcoming vaccination(s)
All parents/caregivers of children in participating villages will receive access to a digital vaccine card. This will be used for record-keeping application (digital vaccine registry). Selected parents/caregivers of children will receive SMS messages and reminders related to vaccination.
Sponsors & Collaborators
-
African Population and Health Research Center
collaborator OTHER - lead OTHER
Principal Investigators
-
Emily Treleaven, PhD, MPH · University of Michigan
-
Gershim Asiki, MBChB, MSc, PhD · African Population and Health Research Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Day
- Max Age
- 24 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-06
- Primary Completion
- 2025-10-29
- Completion
- 2025-10-29
Countries
- Kenya
- Uganda
Study Locations
More Related Trials
-
Mobile and Scalable Innovations for Measles Immunization: a Randomized Controlled Trial
NCT02904642 ·Status: COMPLETED ·Phase: NA
-
Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda
NCT04177485 ·Status: COMPLETED ·Phase: NA
-
Measles Vaccination at Health System Contacts
NCT04220671 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
VISTA: Vaccinator-Initiated Screening and TAilored Counseling for Reducing Vaccine Hesitancy
NCT04421586 ·Status: COMPLETED ·Phase: NA
-
Trial of Additional Measles Vaccine to Reduce Child Mortality. Burkina Faso.
NCT01668745 ·Status: COMPLETED ·Phase: PHASE4
-
Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in Pakistan
NCT03341195 ·Status: UNKNOWN ·Phase: NA
-
mHealth to Increase Measles Immunization - a Randomized Controlled Trial in Guinea-Bissau
NCT02662595 ·Status: UNKNOWN ·Phase: NA
-
Earlier Prime-BOOST Schedule to Improve MEasles Protection in High Burden Settings
NCT06667206 ·Status: RECRUITING ·Phase: PHASE2
-
Role of mHealth-based Interventions Including Social Media to Improve Childhood Immunization Coverage During COVID 19 Pandemic in Pakistan: Qualitative Study
NCT05042011 ·Status: UNKNOWN
-
Testing the Use of Prompts to Increase Adolescent Immunization Rates
NCT01984125 ·Status: COMPLETED ·Phase: NA
-
Trial of Additional Measles Vaccine to Reduce Child Mortality
NCT01644721 ·Status: COMPLETED ·Phase: PHASE4
-
Improving Uptake of Pediatric Vaccines Through Religious Conferences and Vaccines-in-a-van in Aceh, Indonesia
NCT06160999 ·Status: COMPLETED ·Phase: NA
-
A Second Dose of Measles Vaccine (MV) in the Second Year of Life
NCT02943681 ·Status: COMPLETED ·Phase: NA
-
Increasing Vaccine Uptake Among Adolescents in the Rural South
NCT04999267 ·Status: COMPLETED ·Phase: NA
-
Measles Vaccine: Is There a Protective Role in COVID 19 Pandemic?
NCT04445610 ·Status: UNKNOWN
-
ARISe at UMass Chan
NCT07236034 ·Status: RECRUITING ·Phase: NA
-
Call for Life: Exploring mHealth Solutions for Enhancing Childhood Vaccinations Among Displaced Children in Conflict-affected Settings of Nigeria
NCT07154836 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
The Effect of ShotBlocker on Pain and Satisfaction During Measles-Rubella-Mumps Vaccination
NCT06762938 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial to Assess the Safety of a Measles Vaccine (Dry Powder) Administered by Two Different Devices
NCT01557699 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living With and Without HIV in South Africa
NCT05539989 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Pertussis Immunization Programs in Low Income Countries
NCT02983487 ·Status: COMPLETED
-
Measles Vaccine in HCW
NCT04357028 ·Status: SUSPENDED ·Phase: PHASE3
-
A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers
NCT00423839 ·Status: COMPLETED ·Phase: PHASE1
-
Revaccination of Young Children With Bacille Calmette Guerin (BCG) Vaccine
NCT00126217 ·Status: TERMINATED ·Phase: PHASE4
-
Study to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and Adults
NCT06062238 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3